Sorbitol based proniosomes to improve the permeability and stability of an oral cephlosporin
Keywords:
Sorbitol Based Proniosomes, PermeabilityOralAbstract
In the present study, dry free-flowing proniosomes containing Cefuroxime axetil has been prepared with sorbitol. Span 40, 60 and 80 have been used in different molar ratios with cholesterol and stearylamine. Proniosomes are characterized by SEM, flowability, entrapment efficiency, release study and ex-vivo permeation study. Stability study of proniosomes has been determined at roomtemperature. The vesicle size is found to be less than 5µm. Decreased angle of repose indicates the coating of niosomes with sorbitol carrier. Entrapment efficiency of Span 60 is found to be maximum. Both proniosomes and niosomes indicate the similar controlled release profile. Permeation study of cefuroxime axetil, follows the order of Span 60 with bile salt > Span 60 only > Span 40. Upon ageing, proniosomes indicate no change in its physical property and the entrapment efficiency is found to be more than 90%, indicating no leakage or degradation of drug from proniosomes whereas niosomes indicate slight sedimentation and aggregation of particles. These factors indicate the commercial viability and easy scale up of proniosomes.
References
A. Sintov, R.J. Levey, Polymeric drug delivery of enzymatically degradable pedant agents: Peptidyl- linked procainamide model system studies, Int. J. Pharm. 146 (1997) 55-62.
A. Singh, S.K. Singh, P. Goyal, S.G. Vijay Kumar, D.N. Mishra, Design and development of niosomal delivery system, Pharma Times 36 (2004) 11-14.
D. Kaushik, P.R. Mishra, S. Talegaonkar, Provesicles as surrogate carrier for improved drug delivery, in: N.K. Jain (First Eds.), Progress in Controlled and Novel Drug Delivery System, CBS Publishers and Distributors, Delhi, 2004, pp 259-266.
A.D. Bangham, R.W. Home, Negative staining of phospholipids and their structure modification by surface active agents as observed in the electron microscope, J. Mol. Biol. 8 (1994) 660-668.
Tripathi, K.D., Beta Lactamase Inhibitors, in Essentials of medical Pharmacology (Sixth Eds.) Jaypee Publishers, Delhi, 2010 pp 703-709.
N. Ruiz-Balaguer, A. Nacher, V.G. Casabo, M. Merino Sanjuan, Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes, Int. J. Pharm. 234 (2002) 101-111.
K. Habucky, Methods to assess absorption in drug discovery, in: P.G. Welling, F.L.S. Tse, (Second Eds.), Pharmacokinetics-Regulatory-Industrial-Academic Perspective, Marcel Dekker, 67, 1995, 22-28.
M. Zajac, A. Jelinska, L. Dobrowolski, I. Oszczapowicz, Evaluation of stability of cefuroxime axetil in solid state, J. Pharm. Bio Anal. 32 (2003) 1181-1187.
A. De la Maza, J.L. Parra, J.S. Leal, Alteration of permeability of neutral and electronegatively charged liposome by alkyl sulphate surfactants, Langmuir 8 (1992) 2422-2426.
B.J. Aungust, H. Saitoh, D.L. Burcham, S.M. Huang, S.A. Mousa, M.A. Hussain, Enhancement of intestinal absorption of peptides and non-peptides, J. Contr. Rel. 41 (1996) 19-31.
R.L. Juliano, Microparticulate Drug Carriers: Liposomes, Microspheres, and Cells, in V.H.L. Lee (Second Eds. Revised and expanded), Controlled drug delivery- Fundamentals and Applications, Marcel Dekker, 1987, 555-580.
R. Schubert, H. Jaroni, J. Schoelmerich, K.H. Schmidt, Studies on the mechanism of bile salt-induced liposomal membrane damage, Digestion 28 (1983) 181-190.
A. Rogerson, J. Cummings, N. Willmott, A.T. Florence, The distribution of doxorubicin in mice following administration in niosomes, J. Pharm. Pharmcol. 40 (1988) 337-342.
K.S. Chandraprakash, N. Udupa, G.K. Pillai, P. Umadevi, Pharmacokinetic evaluation of surfactant vesicle- entrapped methotraxate in tumor-bearing mice, Int. J. Pharm. 61 (1990) R1-R4.
T. Yoshioka, A.T. Florence, Vesicles(niosomes)-in-water-in-oil (v/w/o) emulsions: an in-vitro study, Int. J. Pharm. 108 (1994) 117-123.
P. Arunothayanun, I.F. Uchegbu, A.T. Florence, Osmotic behavior of polyhedral non-ionic surfactant vesicles (niosomes), J. Pharm. Pharmcol. 51 (1999) 651-657.
L.E. Echegoyan, J.C. Hernandaz, A.E. Karfer, G.W. Gokel, L. Echegoyan, Aggregation of steroidal lariat ethers: the first example of non-ionic liposomes (niosomes) formed from neutral crown ether compounds, J. Chem. Soc. Chem. Commun. 12 (1988) 836-839.
J.A. Darwish, I.F. Uchegbu, The evaluation of crown based niosomes as cation containing and cation sensitive drug delivery system, Int. J. Pharm. 159 (1997) 207-210.
A.J. Baillie, A.T. Florence, L.R. Hume, G.T. Muirhead, A. Rogerson, The preparation and properties of niosomes-non-ionic surfactant vesicles, J. Pharm. Pharmcol. 37 (1985) 863-868.
A.J. Baillie, G.H. Coombs, T.F. Dolan, J. Laurie, Non-ionic surfactant vesicles, niosomes, as a drug delivery system for the anti-leishmanial drug sodium stilogluconate, J. Pharm. Pharmcol. 38 (1986) 502-505.
C.M. Yoshida, Kok W. Lehr, H.E. Junginger, J.C. Verhoef, J.A. Bouwastra, Niosomes for oral delivery of peptide drugs, J. Contr. Rel. 21 (1992) 145-154.
Y. Hao, F. Li H. Zhao, Y. Li K Yang, Studies on high encapsulation of colchicines by a niosome system, Int. J. Pharm. 244 (2002) 73-80.
D. Dimitrijevic, C. Lamandin, I.F. Uchegbu, A.J. Shaw, A.T. Florence, Effects of some non-ionic surfactants on Transepithelial Permeability in Caco-2 cells, J. Pharm. Pharmacol. 49 (2000) 611-615.
I.F. Uchegbu, R. Duncan, Niosomes containing N-(2-hydroxy propyl) methacrylamide copolymer-doxorubicin (PK-1): effects of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution, Int. J. Pharm. 155 (1997) 7-17.
T.R. Desai, W.H. Finlay, Nebulization of niosomal all trans-retinoic acid: an inexpensive alternative to conventional liposomes, Int. J. Pharm. 241 (2002) 311-317.
S.P. Vyas, I.F. Uchegbu, Non-ionic surfactant based vesicles (Niosomes) in drug delivery, Int. J. Pharm. 172 (1998) 33-70.
C. Hu, D.G. Rhodes, Proniosome: A Novel Drug Carrier Preparation, Int. J. Pharm. 185 (1999) 23-35.
B. Vora, A.J. Khopade, N.K. Jain, Proniosome based transdermal delivery of levonorgestral for effective contraception, J. Contr. Rel. 54 (1998) 149-165.
P. Ruiz-Carretero, M. Merino-Sanjuan, A. Nacher, V.G. Casabo, Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime, Eurp. J. Pharm. Sci. 21 (2004) 217-223.
A.T. Florence, Non-ionic surfactant vesicles- alternative to drug delivery? In: L.F. Prescott, W.S. Nimmo, (Eds.) Novel Drug Delivery and its Therapeutic Application, Wiley, London, 1989, pp. 285-295.
E. Touitou, H.E. Junginger, N.D. Werner, T. Nagai, M.J. Mezer, Liposome as carriers for topical and transdermal delivery, J. Pharm. Sci. 83 (1994) 1189-1203.
H.J. Robson, D.Q.M. Craig, D. Deutsch, An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: The influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres, Int. J. Pharm. 190 (1999) 183-192.
H.J. Robson, D.Q.M. Craig, D. Deutsch, An Investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part II: The use of DSC and HSDSC as means of characterizing the interaction of the microspheres with buffered media, Int. J. Pharm. 201 (2000) 211-219.
K.R. Sireesha, D.V. Mhaske, S.S. Kadam, S.R. Dhaneswar, Development and validation of a HPTLC method for simultaneous estimation of cefuroxime axetil and probenecid, Ind. J. Pharm. Sci. 66 (2004) 278-282.
D.C. Wali, T.R.S. Satheeshmanikandan, S.S. Kadam, S.R. Dhaneshwar, Simultaneous spectrophotometric estimation of cefuroxime axetil and probenecid from combined dosage form, Ind. J. Pharm. Sci. (2003) 90-94.
K.P. Hunfeld, R. Rodel, T.A. Wichelhaus, In vitro activity of eight oral cephalosporins against Borrelia burgdorferi, Int. J. Antimirob. Agents, 21 (2003) 313-318.
